bioRxivCancer BiologyPreprint
Deep Learning Bridges Histology and Transcriptomics to Predict Molecular Subtypes and Outcomes in Muscle-Invasive Bladder Cancer
Alice BlondeliD, Clémentine Krucker, Valentin HarteriD, Melissa Da Silva, Clarice S. GroeneveldiD, Aurélien de ReynièsiD, Maryam KarimiiD, Simone BenhamouiD, Isabelle Bernard‐PierrotiD, Christian PfisteriD, Stéphane CulineiD, Yves AlloryiD, Thomas WalteriD, Jacqueline FontugneiD
Abstract
Muscle-Invasive Bladder Cancer (MIBC) is a heterogeneous disease with distinct molecular subtypes influencing prognosis and therapeutic response. However, molecular profiling through RNA sequencing remains costly, time-consuming and complicated by intratumoral heterogeneity. We developed a Deep Learning (DL) approach to infer molecular subtypes from routine histopathological slides and to evaluate its prognostic value in patients treated with neoadjuvant chemotherapy (NAC). We developed an DL-model predicting the expression of 848 subtype-associated genes from histological images of transurethral resection of bladder tumor, enabling spatial molecular subtyping at tile level. The model was trained on 297 NAC-treated patients from the VESPER clinical trial and evaluated on three independent cohorts (COBLAnCE, n=224; Saint-Louis, n=30 and TCGA, n=315), covering diverse staining protocols and scanner types. Spatial transcriptomics from six VESPER patients confirmed the spatial consistency of the inferred expression profiles. Our approach achieved a ROC AUC of 0.94 for molecular subtype prediction, with 95% of genes significantly predicted, demonstrating its ability to capture transcriptomic dysregulations from histological morphology. Predicted expression maps revealed spatially coherent patterns and intratumoral molecular heterogeneity. Importantly, tumors predicted with basal/squamous features (pure or mixed), were associated with significantly worse progression-free and overall survival after NAC (log-rank p=0.014 and 0.037, respectively). This DL-based framework enables accurate and spatially resolved inference of gene expression and molecular subtypes in MIBC without sequencing. These findings could improve patient stratification in clinical practice and support the design of more targeted clinical trials. Further validation in larger cohorts is needed before routine clinical implementation.
- organism: human
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: deep learning
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A consensus molecular classification of muscle-invasive bladder cancer
A. Kamoun, A. de Reynies, … The Bladder Cancer Molecular Taxonomy Group·bioRxiv·Apr 27, 2019
- Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
- Identification of immunological features enables survival prediction of muscle-invasive bladder cancer patients using machine learning
C. G. Gavriel, N. Dimitriou, … P. D. Caie·bioRxiv·Feb 24, 2020
- Transcriptomics-Driven Machine Learning Models Accurately Predict Chemotherapy Response in Muscle-invasive Bladder Cancer
Ariadna Acedo-Terrades, Alejo Rodriguez-Vida, … Joaquim Bellmunt B·medRxiv·Jun 28, 2024
- Predicting molecular subtypes of breast cancer using pathological images by deep convolutional neural network from public dataset
Nam Nhut Phan, Chi‐Cheng Huang, Eric Yao-Yu Chuang·bioRxiv·Feb 12, 2020
- Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer
Hafdís Birta Johansson, Fredrik Liedberg, … Gottfrid Sjödahl·Bladder CancerPeer-reviewed·Jun 1, 2025